On February 18, 2020 Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, reported that management will host a conference call and webcast to discuss its fourth quarter and full year 2019 financial results and present at upcoming investor conferences (Press release, Epizyme, FEB 18, 2020, View Source [SID1234554444]). Details of the events are below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Fourth Quarter and Full-Year 2019 Financial Results: Management will host a conference call and webcast to discuss its fourth quarter and full year 2019 financial results on Monday, Feb. 24, 2020 at 8:30 a.m. ET. To participate in the conference call, please dial (877) 844-6886 (domestic) or (970) 315-0315 (international) and refer to conference ID 9045277.

Upcoming Investor Conference Presentations: Management will present at the following upcoming conferences:
9th Annual SVB Leerink Global Healthcare Conference on Tuesday, Feb. 25, 2020 at 1:00 p.m. ET in New York City;
Cowen and Company’s 40th Annual Healthcare Conference on Monday, March 2, 2020 at 3:30 p.m. ET in Boston;
Barclays Global Healthcare Conference on Tuesday, March 10, 2020 at 2:05 p.m. ET in Miami; and,
Oppenheimer 30th Annual Healthcare Conference on Tuesday, March 17, 2020 at 3:55 p.m. ET in New York City.
Live webcasts will be available in the investor section of the company’s website at www.epizyme.com. The webcasts will be archived for 60 days following the call and presentations.